铁1,10-菲咯啉/MCM-41催化苯酚羟化反应的研究

MCM-41分子筛是最近美国Mobil公司开发出的一种新材料,其孔径范围在2.0～25nm之间,具有较大的Si/Al比和大的比表面积及孔隙率,孔道大小均匀.其对弱极性的环状及芳族化合物具有较大的吸附能力.自这种新型分子筛合成以来,才开始应用于石油炼制及烯烃裂解,歧化的研究.至今还没有关于将MCM-41作为载体,用于负载金属配合物催化剂的报道.本文利用自己合成的MCM-41分子筛作为载体,制成了负载铁的1,10-菲咯啉配合物催化剂(简记FePhen/MCM-41),并将其应用于苯酚的羟化反应,发现其对苯酚的羟化反应具有较好的催化性能.1 实验部分1.1 FePhen/MCM-41的制备将参考文献[3]制得的MCM-41分子筛,取5g放入200mL0.05mol/L的[Fe(Phen)_3]Cl_2乙醇溶液中,室温搅拌24h,抽滤,所得固体用乙醇洗涤3次,以除去MCM-41分子筛表面和孔道内结合不牢的金属配合物.利用原子吸收光谱分析仪,测得负载催化体系中铁元素的含量为0.65%.1.2 MCM-41分子筛及FePhen/MCM-41的表征

Fabrication, characterization of spherical CaWO4:Ln@MCM-41(Ln=Eu3+, Dy3+, Sm3+, Er3+) composites and their applications as drug release systems

Spherical MCM-41 particles with a diameter of about 150 nm have been successfully coated with CaWO4:Ln (Ln = Eu3+, Dy3+, Sm3+, Er3+) phosphor layers through a simple Pechini sol-gel process. The obtained CaWO4:Ln@MCM-41 composites, which kept the mesoporous structure of MCM-41 and the luminescent properties of phosphors, were investigated as a drug delivery system using aspirin (ASPL) as a model drug.

MCM-41 functionalized with YVO4 : Eu3+: a novel drug delivery system

Luminescence functionalization of ordered mesoporous MCM-41 silica was realized by depositing a YVO4:Eu3+ phosphor layer on its surface via the Pechini sol-gel process. This material, which combines the mesoporous structure of MCM-41 and the strong red luminescence property of YVO4: Eu3+, has been studied as a host carrier for drug delivery/release systems. The structure, morphology, texture and optical properties of the materials were well characterized by x-ray diffraction ( XRD), Fourier infrared spectroscopy ( FT-IR), transmission electron microscopy ( TEM), N-2 adsorption and photoluminescence ( PL) spectra. The results indicated that the specific surface area and pore volume of MCM-41, which were directly correlated to the drug-loading amount and ibuprofen ( IBU) release rate, decreased in sequence after deposition of YVO4:Eu3+ and loading of IBU as expected. The IBU-loaded YVO4:Eu3+@ MCM-41 system still showed red luminescence under UV irradiation ( 365 nm) and a controlled release property for IBU. In addition, the emission intensity of Eu3+ increases with an increase in the cumulative released amount of IBU, making the extent of drug release easily identified, tracked and monitored by the change of luminescence, which demonstrates its potential application in drug delivery/release systems.